CN102786596A - Single-chain antibody KGH-R1-ScFv for resisting p21Ras protein and application thereof - Google Patents

Single-chain antibody KGH-R1-ScFv for resisting p21Ras protein and application thereof Download PDF

Info

Publication number
CN102786596A
CN102786596A CN2012103218945A CN201210321894A CN102786596A CN 102786596 A CN102786596 A CN 102786596A CN 2012103218945 A CN2012103218945 A CN 2012103218945A CN 201210321894 A CN201210321894 A CN 201210321894A CN 102786596 A CN102786596 A CN 102786596A
Authority
CN
China
Prior art keywords
cell
chain antibody
scfv
p21ras
kgh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012103218945A
Other languages
Chinese (zh)
Inventor
杨举伦
胡奇婵
陈玥
王丽
丁峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012103218945A priority Critical patent/CN102786596A/en
Publication of CN102786596A publication Critical patent/CN102786596A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides a single-chain antibody KGH-R1-ScFv for resisting p21Ras protein and application of the single-chain antibody KGH-R1-ScFv, belonging to the field of medical biology, and particularly relates to a recombination human adenovirus vector Ad-hrGFP-ScFv with a single-chain antibody coding gene KGH-R1-ScFv. The single-chain antibody provided by the invention can specifically recognise and perform antagonism to p21Ras proteins with different sources, different tissues and different cell strains in a broad-spectrum way, and also can inhibit the proliferation capacity and invasion capacity of human tumor cell of p21Ras protein with high expression in vitro, reduce the ratio of cells in cell division period, and inhibit the growth of transplantation tumor of human tumor cell of p21Ras protein with high expression in mice.

Description

Proteic single-chain antibody KGH-R1-ScFv of a kind of anti-p21Ras and application thereof
Technical field
The invention belongs to the Medical Biology field, relate in particular to proteic single-chain antibody KGH-R1-ScFv of a kind of anti-p21Ras and application thereof.
Background technology
Tumour, especially malignant tumour, serious harm human life and health.Carry out the study on prevention of malignant tumour, for the generation of prophylaxis of tumours, reduce the tumour incidence, reduce mortality ratio, guiding clinical treatment etc., all be of great practical significance.
The Ras gene is a kind of important proto-oncogene, participates in the generation and the development of kinds of tumors.Its expression product Ras albumen is participated in proliferation of cells, growth, differentiation, apoptosis as important molecular switch.Research shows, the ras transgenation with (or) to cross the generation of expressing with tumour very close with the development relation for Ras albumen, in the pathological process of kinds of tumors, plays important effect.Therefore, people have carried out comparatively deep research to the signal transduction pathway of Ras gene, Ras albumen and participation thereof.
The Ras gene is one of proto-oncogene of finding the earliest, is found in Harvery murine sarcoma virus and Kirsten murine sarcoma virus the earliest.The Ras gene is conservative relatively in evolution, extensively is present in the various eukaryotes.Mammiferous Ras gene family has three members, i.e. H-ras, and K-ras, N-ras, in human chromosome, they are positioned 11p14.1 respectively, and 12p12.1/12q24.2 is on the 1p13.2 karyomit(e).The Ras gene has similar structure, forms by four exons, is distributed on the DNA of the about 30kb of total length, and the molecular weight that coding is made up of 188-189 amino acid is the protein of 21KD, so be called p21Ras albumen.
P21Ras albumen is that the GTP/GDP of film mating type is conjugated protein, is positioned the cytolemma inboard.P21Ras albumen has more weak GTP enzymic activity, with GTP and GDP very strong affinity is arranged.Under the normal circumstances, p21Ras combines not active with GDP.When extracellular growth and differentiation factor was transmitted to the inboard p21Ras albumen of after birth to signal, what can strengthen p21Ras albumen and GTP combined actively, makes p21Ras albumen become state of activation, the signalling system opening.Because the existence of GTP enzymic activity, p21Ras albumen can make GTP be hydrolyzed into GDP, p21Ras albumen becomes inactivated state, and signalling system is closed.After p21Ras albumen and GDP combine, can activate guanylic acid and discharge albumen (GNRP), GNRP makes p21Ras albumen discharge GDP and combines GTP.Therefore, can abstemiously regulate of the opening and closing of p21Ras albumen, accomplish the adjusting of pair cell factor signal conductive process signalling system through the mutual conversion of GTP and GDP.
After being activated, the Ras proto-oncogene becomes the oncogene that carcinogenic activity is arranged.The mode of Ras gene activation has 3 kinds: point mutation, gene great expression, gene insert and transposition.After the Ras gene was activated, the proteic configuration of its expression product Ras also changed, and weakened with the binding ability of GDP, and did not need the stimulation of extraneous growth signals to get final product activation after GTP combines; Simultaneously Ras albumen intrinsic GTP enzymic activity reduces, cause that Ras albumen combines, regulates with GTP/GDP unusually, the Ras albumen of active state activates the downstream signal path constantly, causes cell can not breed with controlling, cancerate, while apoptosis minimizing.
Along with the development of Protocols in Molecular Biology and genetic engineering technique, the biological procedures that tumour forms is further illustrated, and the new biotherapy pattern of oncotherapy is applied to clinical gradually and has shown good curative effect.Tumor biotherapy is divided into immunotherapy of tumors and therapy of tumor again.Gene therapy is meant foreign gene imported target cell, with correct or compensation because of genetic flaw, the disease that causes unusually, reach therapeutic purpose.Along with the development of cell signalling and antibody engineering technology, the intrabody technology also has been born.Intrabody is meant at cell inner expression and is located in subcellular compartment (like karyon, endochylema or some organoid), with specific target molecule effect processing, secretion or the function of blocking-up target molecule (disturb or) thus bring into play one type of new engineered antibody of its biological function.
Be used for the complete antibody of tumor biotherapy because molecular weight is bigger, its vascular permeability is weak, diffuse into ability in the tumour, long half time, immunogenicity are strong, and limited its targeted delivery and tumour antagonism effect.The characteristics of intrabody cell inner expression provide a kind of effective this type of antagonism p21Ras albumen to be positioned the inboard proteic method of cytolemma.Prepare a kind of intrabody, can in tumour cell, express anti-p21Ras protein product, p21Ras protein signal transduction pathway in the blocking-up tumour cell, restriction growth of tumor and diffusion are expected to reach the purpose of all kinds of tumours that treatment Ras albumen causes.
Summary of the invention
The invention provides the proteic single-chain antibody coding gene sequence of a kind of anti-p21Ras, and the application of this sequence.
The proteic single-chain antibody KGH-R1-ScFv of a kind of anti-p21Ras of the present invention is characterized in that this antibody coding gene order is shown in SEQ ID NO1.
SEQ?ID?NO1:
>KGH-R1-ScFv?(DNA)
GCGGCCCAGCCGGCCATGGCCCAGGTGAAGCTGCAGGAGTCTGGGGAAGGCTTAGTGAAGCCTGGAGGGTCCCTGAAACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTGACTATTACATGTATTGGGTTCGCCAGACTCCGGAAAAGAGGCTGGAGTGGGTCGCAATCATTAGTGATGGTGGTAGTTACACCTACTATCCAGACAGTGTGAAGGGGCGATTCACCATCTCCAGAGACAATACCAAGAAAAACCTGTACCTGCAAATGAGCAGTCTGAGGTCTGAGGACACAGCCATGTATTACTGTGCAAGAGATCCCCATTACTCCGGTAGTAGCCGCCTGTTTGTTAACTGGGGCCAAGGCACCACGGTCACCGTCTCCTCAGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGATCGGACATCGAGCTCACTCAGTCTCCAGCTTCCTTAGCTGTATCTCTGGGGCAGAGGGCCACCATCTCATACAGGGCCAGCAAAAGTGTCAGTACATCTGGCTATAGTTATATGCACTGGAACCAACAGAAACCAGGACAGCCACCCAGACTCCTCATCTATCTTGTATCCAACCTAGAATCTGGGGTCCCTGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACCCTCAACATCCATCCTGTGGAGGAGGAGGATGCTGCAACCTATTACTGTCAGCACATTAGAGAGCTTACACGTTCGGAGGGGGGACCAAGCTGGCAAATCAAACGGGCGGCCGCAGGTGCGCCGGTGCCGTATCCGGATCCGCTGGAACCGCGTGCCGCATAG
>KGH-R1-ScFv?(Amino?acid)
AAQPAMAQVKLQESGEGLVKPGGSLKLSCAASGFTFSDYYMYWVRQTPEKRLEWVAIISDGGSYTYYPDSVKGRFTISRDNTKKNLYLQMSSLRSEDTAMYYCARDPHYSGSSRLFVNWGQGTTVTVSSGGGGSGGGGSGGGGSDIELTQSPASLAVSLGQRATISYRASKSVSTSGYSYMHWNQQKPGQPPRLLIYLVSNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHIRELTRSEGGPSWQIKRAAAGAPVPYPDPLEPRAA-
Described single-chain antibody gene is inserted into pMD19-T (D102A; Obtain from Takara company) carrier and transformed into escherichia coli DH5 α; The bacillus coli DH 5 alpha KGH-R1-ScFv (Escherichia coli DH5 α KGH-R1-ScFv) that obtains; Be preserved in Chinese typical culture collection center (address be Chinese Wuhan Wuhan University), preserving number CCTCC NO:M2011322 on September 18th, 2011.
Described single-chain antibody gene obtains recombinant human adenovirus carrier Ad-hrGFP-ScFv after inserting adenovirus hominis Ad5 and transfection HEK293 cell; Be preserved in Chinese typical culture collection center (address be Chinese Wuhan Wuhan University), preserving number CCTCC NO:V201219 on May 3rd, 2012.
In order to realize goal of the invention, the present invention adopts following technical scheme:
1, the amplification of light, the variable region of heavy chain of single-chain antibody encoding sox:
(be preserved in Chinese typical culture collection center on September 23rd, 2011 with the proteic hybridoma cell strain KGH-R1 of anti-p21Ras; The address is Chinese Wuhan Wuhan University; Preserving number CCTCC NO:C201197) cDNA is a template; Use the special antibody gene amplimer of mouse increase respectively light, the variable region of heavy chain of antibody coding gene, and through overlapping extension PCR use that flexible oligonucleotide will increase gently, the variable region of heavy chain fragment connects into complete single-chain antibody encoding sox.
2, the structure of recombinant phage plasmid library:
Method through PCR is introduced restriction enzyme site to the single-chain antibody encoding sox that amplification obtains; Cut enzyme mode even through enzyme again the single-chain antibody encoding sox is connected into the phage vector pCANTAB-5E (obtaining from Pharmacia company) that has same restriction enzyme site, obtain the recombinant phage plasmid library thereby make up.
3, the structure of phage single-chain antibody display libraries:
With recombinant phage plasmid library transformed into escherichia coli TG1 (obtaining), obtain the initial library of single-chain antibody from Lucigen company.Add helper phage M13KO7 (27-1524 obtains from GE healthcare company), collect the nutrient solution supernatant, obtain the phage single-chain antibody display libraries.
4, the separation of positive bacteriophage:
Through the method for indirect ELISA, be antigen coated Tissue Culture Plate with p21Ras albumen, being antibody with the phage single-chain antibody display libraries combines the antigen of coated cell culture plate.Add e. coli tg1 and pair discharge, add helper phage M13KO7, cultivate the back and separate supernatant, obtain the positive bacteriophage of enrichment screening with antigen bonded phage.Repeat enrichment screening process 2 times, obtain positive bacteriophage.Positive bacteriophage behind the transformed into escherichia coli TG1, checks order to the extraction plasmid again, obtains inserting fragment sequence, i.e. single-chain antibody KGH-R1-ScFv coding gene sequence.
5, the solubility expression of single-chain antibody:
The positive colony of transformed into escherichia coli TG1 adds N,O-Diacetylmuramidase thalline is carried out cracking after IPTG (obtaining from Sigma company) induces, and the gained supernatant is the single-chain antibody of solubility expression.
6, the detection of single-chain antibody antigen binding characteristic:
Collecting the different tumor cell line of 19 strains, is respectively human stomach cancer cell line BGC-853, MKN28, human hepatoma cell strain QGY-7703, SMMC-7721, HepG2; Human breast cancer cell strain MDA-MB-231, MDA-MB-435, MCT-7; Human leukemia cell line THP-1, K562, MT4 CD4+, Daud I, C8166 CD4+, HL60, human cervical carcinoma cell strain HeLa, people's larynx squamous cell carcinoma strain Hep-2; Human oophoroma cell line SKOV3; People's colorectal cancer cell strain HCT116, human bladder cancer cell's strain T-24 (19 strain cell strains are all from typical case's culture collection council of Chinese Academy of Sciences cell bank) carries out film-making by routine immunization group program; With the single-chain antibody of solubility expression is one anti-; HRP/Anti-E-tag (ab3415-250, from GE healthcare company obtain) is two anti-, identifies the antigen binding characteristic of single-chain antibody.
7, the structure of recombinant adenovirus plasmid:
Method through PCR is introduced restriction enzyme site to the single-chain antibody encoding sox of identifying, cuts enzyme mode even through enzyme again and the single-chain antibody encoding sox of identifying is connected into the shuttle plasmid pShuttle-IRES-hrGFP-1 (obtaining from Stratagene company) that has same restriction enzyme site.Recombinant shuttle plasmid is after Pme I (obtaining from Takara company) linearization for enzyme restriction, dephosphorylation are handled, and electricity transforms BJ5183-AD-1 (obtaining from Stratagene company) cell.Homologous recombination takes place in the skeleton plasmid pAdEasy-1 that has existed in linear recombinant shuttle plasmid and the BJ5183-AD-1 cell (D102A obtains from Takara company), produces recombinant adenovirus plasmid.
8, the preparation of recombinant adenovirus:
Recombinant adenovirus plasmid is carried out Pac I enzyme cut, reclaim the endonuclease bamhi that enzyme is cut about 30 Kb size of generation.With the endonuclease bamhi mixing transfection reagent Lipofectamine that reclaims TM2000, transfection HEK293 cell (from typical case's culture collection council of Chinese Academy of Sciences cell bank).In the HEK293 cell of transfection success back with packing out ripe adenovirus, thereby obtain recombinant human adenovirus carrier Ad-hrGFP-ScFv.
9, the location of intrabody:
Behind recombinant adenovirus infected person breast cancer cell MDA-MB-231 (from typical case's culture collection council of Chinese Academy of Sciences cell bank) cell, in cell, produce single-chain antibody.Detect it in intracellular location through merging at the terminal FLAG label of single-chain antibody.
10, external inhibition test:
Infect the proteic human breast cancer cell MDA-MB-231 of high expression level p21Ras, human liver cancer cell BEL-7402, human colon cancer cell SW480, Proliferation of Human Ovarian Cell OVCAR3 with recombinant adenovirus; And the proteic Proliferation of Human Ovarian Cell SKOV3 of the low p21Ras of expression (above all from typical case's culture collection council of Chinese Academy of Sciences cell bank): (1) adds the MTT pair cell and cultivates; Through measuring the OD490 absorbance value; Draw the cell viability curve, antibody is to the influence of tumor cell activity in the analysis of cells; (2) tumour cell is prepared into single cell suspension, after certain cell density inoculation, in containing the RPMI RPMI-1640 of 20% NBCS, cultivates 2-3 week.After the Giemsa stain dyeing, counting cells clone number under the inverted microscope, antibody is to the influence of tumor cell proliferation ability in the analysis of cells; (3) tumour cell that infects is inoculated in the Transwell microporous membrane upper surface that matrigel Matrigel encapsulates with certain cell density, cultivate 48 h after, wipe microporous membrane upper surface cell with cotton swab, use fixedly microporous membrane lower surface cell of 95% ethanol.Behind the haematoxylin dyeing, inverted microscope is counting microporous membrane lower surface cell number down, and antibody is to the influence of tumor cell invasion ability in the analysis of cells; (4) 75% ethanol of adding precooling, 4 ℃ of fixed cells spend the night.Add PI dye liquor pair cell and dye, use flow cytometer collecting cell PI fluorescent signal, the influence that antibody distributes to tumour cell cycle in the analysis of cells.
11, inhibition test in the body:
With tumour cell BEL-7402, SW480, SKOV3 (from typical case's culture collection council of Chinese Academy of Sciences cell bank) injection inoculation SPF level female Balb/c nude mice in 4 age in week, nude mice carries out multiple spot adenovirus injection in the knurl after becoming knurl.Injection in per 3 days 1 time is injected 7 times altogether.The injection back is observed nude mice, and knurl body volume is calculated in the long and short footpath of weighing nude mice body weight every other day, and measurement nude mice knurl body, draws tumor growth curve.Antibody is to the restraining effect of tumor growth in the analysis of cells.
Description of drawings
Fig. 1 is light, the variable region of heavy chain of pcr amplification antibody coding gene;
M:Marker, stripe size is followed successively by 600 bp, 500 bp, 400 bp, 300 bp, 200 bp, 100 bp; 1-2: variable region of heavy chain; 3-4: variable region of light chain.
The single-chain antibody gene electrophoresis that Fig. 2 is formed by connecting for light, variable region of heavy chain, M:DL2000.
Fig. 3 expresses the recombinant phage clone of anti-p21Ras albumen single-chain antibody for the ELISA screening;
H-ras, K-ras, N-ras albumen are respectively as antigen coated enzyme plate, and every hole encapsulates 0.5 μ g.The phage supernatant (100 μ l) of 1:200 dilution is anti-as one, and the HRP/Anti-M13 Monoclonal Ccojugate (100 μ l) of 1:2000 dilution is anti-as two, 100 μ l TMB colour developing.It is one anti-that positive control uses the anti-p21Ras protein monoclonal antibody supernatant (100 μ l) of 1:2000 dilution, and sheep anti-mouse igg (1:2000 dilution, 100 μ l) is two anti-; Blank uses PBS solution; Negative control uses helper phage M13KO7 supernatant.Read every hole OD450 value in the ELIASA.
Fig. 4 is the influence figure of intrabody to tumor cell activity.
Fig. 5 is the influence figure of intrabody to the tumor cell proliferation ability.
Fig. 6 is the influence figure of intrabody to the tumor cell invasion ability.
Fig. 7 is the influence figure of intrabody to the tumour cell cycle distribution.
Embodiment
Embodiment 1: proteic single-chain antibody KGH-R1-ScFv of a kind of anti-p21Ras and application thereof, the technical scheme of its acquisition is following:
1, total RNA extraction of anti-p21Ras hybridoma cell strain and cDNA are synthetic
1.1 total RNA extracts
The hybridoma that collection is cultured to logarithmic phase (is preserved in Chinese typical culture collection center on September 23rd, 2011; Preserving number CCTCC NO:C201197); Use Trizol (obtaining),, extract the total RNA of hybridoma according to the reagent operation instruction from Mrcgene company.1.0% agarose gel electrophoresis detects total RNA integrity.NanoDrop 2000 (obtaining) spectrophotometric determination total rna concentration from Thermo company.
1.2 cDNA is synthetic
Use RevertAid TMH Minus First Strand cDNA Synthesis Kit (obtaining from Fermentas company) according to the test kit operation instruction, carries out reverse transcription to total RNA that extracts in 1.1.
2,Hybridoma antibody coding gene is light, the variable region of heavy chain amplification
2.1 antibody coding gene variable region of light chain amplification
Using the special Light Primer Mix in mouse source (27-1583-01 obtains from GE healthcare company), is template with synthetic cDNA in 1.2, pcr amplification antibody coding gene variable region of light chain, operation reference reagent operation instruction.Products therefrom carries out 1.5% agarose gel electrophoresis, detects the electrophoretic band size.
2.2 antibody coding gene variable region of heavy chain amplification
With 2.1, use Heavy Primers 1,2 (27-1586-01 obtains from GE healthcare company), pcr amplification antibody coding gene variable region of heavy chain.
2.3 connecting, light, variable region of heavy chain makes up the ScFv gene fragment
Use DNA purifying and recovering test kit (DP214-02 obtains from Tiangen company),, PCR product in 2.1 and 2.2 is carried out purifying and recovering according to the test kit operation instruction.Utilize overlapping extension PCR principle, use Linker-Primer Mix (27-1588-01 obtains from GE healthcare company), according to the reagent operation instruction, light, the heavy chain variable region gene fragment that reclaim purifying are connected into the ScFv gene, structure is V H-Linker-V L
3,Recombinant phage single-chain antibody display libraries makes up
3.1 ScFv gene restriction enzyme site is introduced
Use RS Primer Mix (27-1589-01 obtains from GE healthcare company),, gained ScFv gene in 2.3 is carried out pcr amplification, introduce restriction enzyme site according to the reagent operation instruction.5 ' end restriction enzyme site is Sfi I, and 3 ' end restriction enzyme site is Not I.
3.2 the ScFv gene connects phage expression vector pCANTAB-5E
Sfi I and Not I (obtaining from Fermentas company) order enzyme is cut gained ScFv gene and phage expression vector pCANTAB-5E (obtaining from Pharmacia company) 3.1.Enzyme is cut product and is carried out 1.0% agarose gel electrophoresis, detects enzyme and cuts effect, and cut glue purification and reclaim (DP214-02 obtains from Tiangen company) ScFv gene fragment and expression vector pCANTAB-5E after enzyme is cut.According to the ratio of gene fragment, use carrier and the ScFv gene fragment of T4 DNA Ligase (obtaining) after ligase enzyme is cut from Fermentas company than carrier 3:1.
3.3 the initial library construction of single-chain antibody
With gained recombinant vectors transformed into escherichia coli TG1 in 3.2 (obtaining) from Lucigen company; Conversion condition is with reference to E.coli Competent Cells DH5 α (D9057A; Obtain from Takara company) working instructions; Cultivating controlled temperature is 30 ℃, converted product coating SOB dull and stereotyped (SOB-AG contains 100 μ g/ml Ampicillin and 2% Glucose).After 30 ℃ of overnight cultures, collect the dull and stereotyped bacterium colony of going up in 2 * YT nutrient solution (2 * YT-AG contains 100 μ g/ml Ampicillin and 2% Glucose).Adding glycerine to final concentration is 25%, and packing is stored in-80 ℃.Gained is the initial library of single-chain antibody.
3.4 recombinant phage single-chain antibody display libraries makes up
Get the initial library of gained in 3.3, in 2 * YT-AG nutrient solution, be cultured to logarithmic phase.The reference reagent operation instruction adds an amount of helper phage M13KO7 (27-1524 obtains from GE healthcare company), cultivates 1 h altogether for 30 ℃.Resuspended 2 * YT nutrient solution (2 * YT-AK contains 100 μ g/ml Ampicillin and 50 μ g/ml Kanamycin), the 30 ℃ of overnight cultures of being deposited in centrifugal back.Supernatant is collected in centrifugal back, adds the PEG8000 (obtaining from Meker company) of 1/5 volume.Centrifugal back is with the resuspended deposition of an amount of PBS, and adding glycerine to final concentration is 25%, and packing is stored in-80 ℃.Gained is the phage single-chain antibody display libraries.
4,The enrichment screening of positive bacteriophage
With the lower section detailed step with reference to Recombinant Phage Antibody System (RPAS, from GE Healthcare company obtain) specification sheets.
4.1 positive bacteriophage enrichment
The resuspended phage single-chain antibody storehouse of gained PBS in 3.4 is joined in the cell bottle that 10 μ g/ml p21Ras albumen encapsulate, cultivate 2 h for 37 ℃.Use PBS solution (PBS-T contains 0.05% Tween-20) wash bottle 3 times, continue with PBS solution wash bottle 3 times again.Gained is the positive bacteriophage of enrichment.
4.2 phage discharges
In the cell bottle of 4.1 enrichment positive bacteriophages, add the e. coli tg1 that is in logarithmic phase in right amount, cultivate 1 h for 30 ℃.Resuspended 2 * YT-AG the nutrient solution that is deposited in centrifugal back, shop 2 * YT-AG is dull and stereotyped.After 30 ℃ of overnight cultures, collect the dull and stereotyped bacterium colony of going up, be cultured to logarithmic phase in 2 * YT-AG nutrient solution.Add an amount of helper phage M13KO7, cultivate 1 h altogether for 30 ℃.Resuspended 2 * YT-AK the nutrient solution that is deposited in centrifugal back, 30 ℃ of overnight cultures.Supernatant is collected in centrifugal back, adds the PEG8000 of 1/5 volume.Centrifugal back is with the resuspended deposition of an amount of PBS, and after recentrifuge, supernatant were crossed 0.45 μ m aperture filter membrane, adding glycerine to final concentration was 25%, is stored in-80 ℃.This is the positive bacteriophage through first round enrichment screening.
4.3 purification enrichment
Repeat above-mentioned enrichment screening process 4.1 and 4.2,2 times, the gained phage is used for further analysis.
4.4 mono-clonal separates
The e. coli tg1 that in 4.3 gained phages, adds logarithmic phase is cultivated 1 h for 30 ℃.Resuspended 2 * YT-AG the nutrient solution that is deposited in centrifugal back, shop 2 * YT-AG is dull and stereotyped.After 30 ℃ of overnight cultures, choose in 48 orifice plates that every hole contains 400 μ l, 2 * YT-AG nutrient solution separating good mono-clonal on the flat board.Every hole is got 40 μ l and is joined in the 48 new well culture plates, adds helper phage M13KO7 (5 * 10 10Pfu/ml) 400 μ l.Cultivate 2 h for 30 ℃, become muddy to liquid.Flat board is centrifugal, carefully absorb supernatant.Every hole adds 400 μ l, 2 * YT-AK nutrient solution, 30 ℃ of overnight cultures.Flat board is centrifugal, and the gained supernatant is mono-clonal phagocytosis body fluid.
5, the positive monoclonal phage identifies
5.1 indirect elisa method is identified positive recombinant clone
Gained phage supernatant in 4.4 is joined in the 96 hole enzyme plates that every hole 0.5 μ g p21Ras albumen encapsulates.Behind 37 ℃ of reaction 1 h, PBS-T solution is washed plate 3 times.Add two anti-HRP/Anti-M13 Monoclonal Ccojugate (27-9421-01 obtains from GE healthcare company), 100 μ l (1:2000 dilution), 37 ℃ of reaction 0.5 h.PBS-T solution is washed plate 3 times, redistillation washing plate 2 times.Add 100 μ l TMB, develop the color in the dark place.Obvious painted hole is the positive monoclonal phage.
5.2 bacterium liquid PCR method is identified positive recombinant clone
With the 5.1 positive bacteriophage supernatants of being identified is template, is primers designed with pCANTAB-5E carrier external source insertion fragment upstream and downstream S1, S6 primer, the phage vector external source is inserted fragment carry out pcr amplification, identifies and inserts clip size.The PCR product carries out 1.0% agarose gel electrophoresis.Wherein, the S1 primer sequence is: 5'-CAACGTCAAAAAATTATTAT TCGC-3', the S6 sequence is: 5'-GTAAATGAATTTTCTGTATGAGG-3'.
5.3 external source is inserted sequencing fragment
Use DNA purifying and recovering test kit,, PCR product in 5.2 is carried out purifying and recovering according to the test kit operation instruction.Reclaim product and connect pMD19-T carrier (D102A obtains from Takara company), the positive colony of screening send the order-checking of the big genome company (BGI) of China, and relating operation is according to the reagent operation instruction.Be the coding gene sequence of purpose single-chain antibody KGH-R1-ScFv after the gained sequencing sequence removal carrier sequence.With order-checking clone transformed into escherichia coli DH5 α, the DH5 α KGH-R1-ScFv of acquisition was preserved in Chinese typical culture collection center, preserving number CCTCC NO:M2011322 on September 22nd, 2011.
6,The solubility expression of single-chain antibody and evaluation
6.1 the solubility expression of single-chain antibody
Behind 5.1 evaluation positive bacteriophages, in 4.4, draw corresponding mono-clonal nutrient solution and carry out enlarged culturing.30 ℃ are cultured to OD600=0.8, centrifugal.The careful supernatant of removing adds freshly prepared 2 * YT nutrient solution (2 * YT-AI contains 100 μ g/ml Ampicillin and 1mM IPTG), induces the single-chain antibody of solubility to express 30 ℃ of overnight cultures.Remove supernatant after centrifugal, with the PBS bacterial sediment that suspends, adding N,O-Diacetylmuramidase (obtaining from Sigma company), to make its final concentration be 1U/ μ l.Digest behind 10 min centrifugally, the gained supernatant is the single-chain antibody of solubility expression.
6.2 the single-chain antibody relative molecular weight is identified
Single-chain antibody to 6.1 resulting solubility expressions carries out SDS-PAGE, identifies the relative molecular weight of single-chain antibody.6.1 gained supernatants are splined on 1 * SDS solution, the 25mA electrophoresis.Under the room temperature, place on the shaking table, Virahol is fixed 15 min, coomassie brilliant blue staining 2 h, and the decolouring of 10% acetate is spent the night.Back reference protein molecular weight standard (Marker) analysis list chain antibody relative molecular weight size has developed the color.
6.3 the antigen binding characteristic of single-chain antibody
Collect the tumor cell line of logarithmic phase; Totally 19 strains comprise: human stomach cancer cell line BGC-853, MKN28, human hepatoma cell strain QGY-7703, SMMC-7721, HepG2; Human breast cancer cell strain MDA-MB-231, MDA-MB-435, MCT-7; Human leukemia cell line THP-1, K562, MT4 CD4+, Daud I, C8166 CD4+, HL60, human cervical carcinoma cell strain HeLa, people's larynx squamous cell carcinoma strain Hep-2; Human oophoroma cell line SKOV3; People's colorectal cancer cell strain HCT116, human bladder cancer cell's strain T-24 (respectively available from typical case's culture collection council of Chinese Academy of Sciences Shanghai cell bank/Kunming cell bank, or Yunnan Province's natural drug key lab).
Collect above-mentioned cell strain in centrifuge tube, supernatant is removed in centrifugal back, precipitates with the saline water washed cell.Recentrifuge is with 95% ethanol re-suspended cell.Recentrifuge adds 95% ethanol, fixed cell 3 h after removing supernatant again.The careful tumour cell piece that takes out, by routine paraffin wax section program dewater, transparent, waxdip, embedding, section, dewaxing, aquation, and antigen high pressure reparation.Immunocytochemistry is carried out in the tumour cell section for preparing to be detected; With the single-chain antibody of 6.1 resulting solubility expressions is one anti-; HRP/Anti-E-tag (ab3415-250; Obtain from GE healthcare company) be two anti-, Streptomycin sulphate avidin-px (SP) is identified the antigen binding characteristic of single-chain antibody to the substrate-function colour developing.
The result shows that the immunity that the single-chain antibody of solubility expression and other tumor cell lines except that leukemia cell line are in various degree is positive, explains that the single-chain antibody of preparation has the immunological competence of the tumor cell line of wide spectrum.
7,The structure of recombinant adenovirus
7.1 the structure of recombinant shuttle plasmid
With the 5.3 pMD19-T vector plasmids that are connected with the single-chain antibody encoding sox identified is template, with the terminal positive anti-primer (5'-GA that has Bgl II and Xho I restriction enzyme site respectively AGATCTTCATGGCCCAGGTGAA-3' and 5'-CC CTCGAGGGCGGCGGGCAAACTAA-3') carry out pcr amplification.The PCR product that amplification obtains carries out 1.5% agarose gel electrophoresis, uses DNA purifying and recovering test kit to reclaim the purpose band of purifying 750 bp size length.Use Bgl II and Xho I restriction enzyme the PCR product and the shuttle plasmid pShuttle-IRES-hrGFP-1 (obtaining) of double digestion recovery respectively from Stratagene company; Whether 1.0% agarose gel electrophoresis detection enzyme is cut complete, cuts glue purification and reclaims through the PCR of double digestion product and shuttle plasmid.Use T4 DNA Ligase to connect PCR product and shuttle plasmid after reclaiming, connect product transformed into escherichia coli DH5 α competent cell, converted product shop LB-kantlex is dull and stereotyped, 37 ℃ of overnight cultures.The finely disseminated conversion bacterium colony of picking carries out PCR with the carrier primer pShuttle-F (5'-CTCACGGGGATTTCCAAGTC-3') of shuttle plasmid and pShuttle-R (5'-ATGCAGTCGTCGAGGAATTG-3') to bacterium colony and identifies.Use TIANprep Mini plasmid extraction kit (DP103-02 obtains from Tiangen company) to identifying that through PCR the male bacterium colony extracts plasmid, use Bgl II and Xho I that the plasmid that extracts is done further enzyme and cut evaluation.Enzyme is cut evaluation male plasmid check order, to guarantee to insert the fragments sequence integrity.
7.2 the structure of recombinant adenovirus plasmid
7.1 recombinant shuttle plasmids identified are carried out Pme I enzyme cut, make its linearizing.After linearizing recombinant shuttle plasmid reclaims purifying, it is carried out CIAP (obtaining from Fermentas company) handle, make its dephosphorylation.The linear recombinant shuttle plasmid electricity that dephosphorylation is handled transforms BJ5183-AD-1 (obtaining from Stratagene company) competent cell, and transformed bacteria liquid coating LB-kantlex is dull and stereotyped, 37 ℃ of overnight cultures.Homologous recombination takes place in the skeleton plasmid pAdEasy-1 that exists in linear recombinant shuttle plasmid and the BJ5183-AD-1 cell; The generation recombinant adenovirus plasmid uses Pac I that recombinant adenovirus plasmid is carried out enzyme and cuts; Enzyme is cut product and is carried out agarose gel electrophoresis, and the evaluation enzyme is cut the clip size of generation.After linear recombinant shuttle plasmid and the skeleton plasmid pAdEasy-1 homologous recombination, can produce the Pac I endonuclease bamhi of about 30 kb size.
7.3 recombinant adenovirus preparation
Reference reagent operation instruction, the Pac I enzyme that mixes 7.2 process of preparing are cut the fragment of about 30 kb size of generation in Lipofectamine TM2000 (the obtaining), transfection reagent is hatched with HEK293 cell (from typical case's culture collection council of Chinese Academy of Sciences cell bank) jointly from Invitrogen company.24 h observe cells transfected under the inverted fluorescence microscope after the transfection, like visible obviously green fluorescence, the transfection success are described then.In the HEK293 cell, pack out ripe adenovirus.The recombinant human adenovirus carrier Ad-hrGFP-ScFv that obtains is preserved in Chinese typical culture collection center, preserving number CCTCC NO:V201219 on June 13rd, 2012.
7.4 adenovirus purifying
After the transfection 10-14 days, swelling appears in most HEK293 cells, become justify, when coming off, assembling agglomerating cytopathic effect, collecting cell.Cell suspension is carried out centrifugal, PBS solution washing, suspension cell.With cell multigelation in-80 ℃ of methyl alcohol/37 ℃ water-baths, 4 times, freeze at every turn, melt each about 5 min.Supernatant is collected in centrifugal back, and packing is stored in-80 ℃.Gained is adenovirus stoste.Adenovirus stoste is further purified through cesium chloride density gradient centrifugation.This method gained adenovirus satisfies the requirement of further experiment.
8,The location of intrabody
7.4 prepared adenovirus are pressed infection multiplicity MOI=100 infected person breast cancer cell MDA-MB-231 (typical case's culture collection council of Chinese Academy of Sciences cell bank); Behind the recombinant adenovirus cells infected; The gene that its plasmid carries is at cell inner expression; Can be through the existence of green fluorescence signal detection adenovirus in the cell, through merge the detection of the terminal FLAG label of single-chain antibody know insertion external source single-chain antibody encoding sox expression and in intracellular location.The MDA-MB-231 cell fixation that method through cell climbing sheet makes logarithmic phase is on slide glass; Behind the adenovirus infection cell 36h; Cell on the slide glass is carried out immunoreation; Add anti-Anti-FLAG (R) M2 Antibody (2368, obtain), two anti-Rhodamine-Conjugated Goat Anti-Rabbit IgG (ZF-0316 from Cell Signaling Technology company; Biomarket company obtains), immunoreation finishes the back and under laser confocal microscope FV1000, observes hrGFP and Rhodamine institute's fluorescence excitation and both confocal fluorescents respectively in intracellular location.
9,Intrabody is to the inhibition research of cancer cells
9.1 the detection of cell viability
With the 7.4 prepared proteic human breast cancer cell MDA-MB-231 of adenovirus infection high expression level p21Ras, human liver cancer cell BEL-7402, human colon cancer cell SW480, Proliferation of Human Ovarian Cell OVCAR3, and the low proteic Proliferation of Human Ovarian Cell SKOV3 of p21Ras that expresses.Simultaneously, set up empty carrier virus group and blank group.Behind adenovirus infection cell 24 h, 36 h, 48 h, 72 h, 96 h, add MTT.After cultivating 4 h, abandon MTT, add DMSO, low-speed oscillation 10 min.Measure the OD490 absorbance value of each sample, each sample is established 3 repetitions.With the infection time is transverse axis; The OD490 absorbance value is the longitudinal axis; Draw the cell viability curve, the intrabody of expressing after the analysis tumour cell infection adenovirus is to the influence of its vigor, and relatively high expression level and the proteic tumor cell line of low expression p21Ras are to the susceptibility of this intrabody.
9.2 the detection of ability of cell proliferation
Experimental cell well-grown, degree of converging reach at 80% o'clock, and it is carried out adenovirus infection, set up the contrast of empty carrier virus group simultaneously.Experimental cell comprises MDA-MB-231 cell, BEL-7402 cell, SW480 cell, OVCAR3 cell, SKOV3 cell (from typical case's culture collection council of Chinese Academy of Sciences cell bank).Use the tryptic digestion attached cell after infecting 24h; Process single cell suspension with the RPMI 1640 that contains 20% NBCS (obtaining) (obtaining) nutrient solution suspension cell from Hyclone company from Gibco company; Density with 250,500,750 cells is inoculated in 6 orifice plates respectively; Each sample is established 3 repetitions, cultivates 2-3 week.After the Giemsa stain dyeing, counting cells clone (single clone's cell count is greater than 50) number calculates cloning efficiency under the inverted microscope BX41.The intrabody of expressing after the analysis comparison of tumor cell infection adenovirus is to the influence of its multiplication capacity.
Cell count * 100% of cloning efficiency (%)=clone's number/inoculation.
9.3 the detection of cell invasion ability
Press the reagent operation instruction, use matrigel Matrigel (from BD Matrigel TMCompany obtains) coated cell cell Transwell microporous membrane.With 9.2, MDA-MB-231 cell, BEL-7402 cell, SW480 cell, OVCAR3 cell, SKOV3 cell (all from typical case's culture collection council of Chinese Academy of Sciences cell bank) are carried out adenovirus infection.Use trypsin digestion and cell after infecting 24 h, process single cell suspension with the RPMI RPMI-1640 suspension cell that contains 2% NBCS, with 3 * 10 4The density of individual cell is inoculated in the Transwell microporous membrane upper surface that matrigel Matrigel encapsulates.In 24 orifice bores of nested Transwell microporous membrane, add the RPMI RPMI-1640 that contains 20% NBCS, cultivate 48 h.After wiping microporous membrane upper surface cell gently with cotton swab, use fixedly microporous membrane lower surface cell of 95% ethanol.Behind the haematoxylin dyeing, inverted microscope is counting microporous membrane lower surface cell number down.The intrabody of expressing after the analysis comparison of tumor cell infection adenovirus is to the influence of its invasive ability.
9.4 the detection of cell cycle
Detect dna content in the cell through flow cytometry iodate third ingot (PI, from Beckman company obtain) staining, divide into the G0/G1 phase mutually, S phase, G2/M phase, the percentage of phase when calculating each during with cell cycle of different cells.With 9.2, MDA-MB-231 cell, BEL-7402 cell, SW480 cell, OVCAR3 cell, SKOV3 (all from typical case's culture collection council of Chinese Academy of Sciences cell bank) cell are carried out adenovirus infection.Use trypsin digestion and cell after infecting 48h, blow and beat into single cell suspension.Each experimental group gets 1 * 10 6Individual cell, the PBS solution washing cell of use precooling 2 times.Add 75% ethanol of precooling, 4 ℃ of fixed cells spend the night.Reuse the PBS solution washing cell 2 times of precooling.Add PI dye liquor pair cell and dye 30 min.Use flow cytometer through flow cytometry collecting cell PI fluorescent signal, wherein excitation wavelength is 488 nm, and wavelength of transmitted light is 620 nm, and each sample collection is more than 10000 fluorescent signals.Use MultiCycle DNA software analysis cell fluorescence intensity, cell cycle distribution, and calculate the cell proliferation index.The intrabody of expressing after the analysis comparison of tumor cell infection adenovirus is to the influence of its cell cycle distribution.
(Proliferation?Index,?PI)=(S+G2/M)/(G0/G1+S+G2/M)?×100%。
10,Intrabody is to the inhibition research of tumor growth
10.1 the foundation of nude mice tumor model
Experimental cell BEL-7402, SW480, SKOV3 well-grown, degree of converging reach at 80% o'clock, use tryptic digestion, collecting cell, behind the PBS solution washing cell cell density are adjusted to 10 7Individual cell/200 μ l is as the single injection consumption.The injection cell for preparing is inoculated in SPF level 4 female Balb/c nude mice in age in week, 10 of every kind of tumor cell inoculations, nude mice is used for the inhibition research of intrabody to tumor growth after becoming knurl.
10.2 intrabody is to the inhibition research of tumor growth
The nude mice injection inoculation divides into groups to it after becoming knurl, 5 every group.When knurl body diameter reaches 0.5 cm, it is carried out multiple spot adenovirus injection in the knurl, set up the contrast of empty carrier virus group simultaneously.Injection volume is 3 * 10 8Pfu/ only injected 1 time, and injected altogether 7 times in per 3 days.The injection back is observed nude mice, and knurl body volume is calculated in the long and short footpath of weighing nude mice body weight every other day, and measurement nude mice knurl body, draws tumor growth curve.The intrabody of expressing after the analysis comparison of tumor injection adenovirus is to the inhibition of its growth.
Knurl body volume=1/2 * major diameter * minor axis 2
SEQUENCE?LISTING
 
< 110>Yang Julun
 
< 120>the proteic single-chain antibody KGH-R1-ScFv of a kind of anti-p21Ras
 
<160> 1
 
<170> PatentIn?version?3.3
 
<210> 1
<211> 822
<212> DNA
<213> KGH-R1-ScFv?(DNA)
 
<400> 1
gcggcccagc?cggccatggc?ccaggtgaag?ctgcaggagt?ctggggaagg?cttagtgaag 60
 
cctggagggt?ccctgaaact?ctcctgtgca?gcctctggat?tcactttcag?tgactattac 120
 
atgtattggg?ttcgccagac?tccggaaaag?aggctggagt?gggtcgcaat?cattagtgat 180
 
ggtggtagtt?acacctacta?tccagacagt?gtgaaggggc?gattcaccat?ctccagagac 240
 
aataccaaga?aaaacctgta?cctgcaaatg?agcagtctga?ggtctgagga?cacagccatg 300
 
tattactgtg?caagagatcc?ccattactcc?ggtagtagcc?gcctgtttgt?taactggggc 360
 
caaggcacca?cggtcaccgt?ctcctcaggt?ggaggcggtt?caggcggagg?tggctctggc 420
 
ggtggcggat?cggacatcga?gctcactcag?tctccagctt?ccttagctgt?atctctgggg 480
 
cagagggcca?ccatctcata?cagggccagc?aaaagtgtca?gtacatctgg?ctatagttat 540
 
atgcactgga?accaacagaa?accaggacag?ccacccagac?tcctcatcta?tcttgtatcc 600
 
aacctagaat?ctggggtccc?tgccaggttc?agtggcagtg?ggtctgggac?agacttcacc 660
 
ctcaacatcc?atcctgtgga?ggaggaggat?gctgcaacct?attactgtca?gcacattaga 720
 
gagcttacac?gttcggaggg?gggaccaagc?tggcaaatca?aacgggcggc?cgcaggtgcg 780
 
ccggtgccgt?atccggatcc?gctggaaccg?cgtgccgcat?ag 822
 
 
< 110>Yang Julun
     
< 120>the proteic single-chain antibody KGH-R1-ScFv of a kind of anti-p21Ras
 
<160> 1
 
<170> PatentIn?version?3.3
 
<210> 2
<211> 273
<212> DNA
<213> KGH-R1-ScFv?(Amino?acid)
 
<400> 1
aaqpamaqvk?lqesgeglvk?pggslklsca?asgftfsdyy?mywvrqtpek?rlewvaiisd 60
 
ggsytyypds?vkgrftisrd?ntkknlylqm?sslrsedtam?yycardphys?gssrlfvnwg 120
 
qgttvtvssg?gggsggggsg?gggsdieltq?spaslavslg?qratisyras?ksvstsgysy 180
 
mhwnqqkpgq?pprlliylvs?nlesgvparf?sgsgsgtdft?lnihpveeed?aatyycqhir 240
 
eltrseggps?wqikraaaga?pvpypdplep?raa 273

Claims (3)

1. the proteic single-chain antibody KGH-R1-ScFv of anti-p21Ras is characterized in that this antibody coding gene order is shown in SEQ ID NO1.
2. the proteic single-chain antibody KGH-R1-ScFv of a kind of anti-p21Ras as claimed in claim 1; It is characterized in that described single-chain antibody gene is inserted into pMD19-T (D102A; Obtain from Takara company) carrier and transformed into escherichia coli DH5 α; The bacillus coli DH 5 alpha KGH-R1-ScFv that obtains is preserved in Chinese typical culture collection center, preserving number CCTCC NO:M2011322 on September 22nd, 2011.
3. the proteic single-chain antibody KGH-R1-ScFv of a kind of anti-p21Ras as claimed in claim 1; It is characterized in that obtaining recombinant human adenovirus carrier Ad-hrGFP-ScFv behind the described single-chain antibody gene transfection HEK293 cell; Be preserved in Chinese typical culture collection center, preserving number CCTCC NO:V201219 on June 13rd, 2012.
CN2012103218945A 2012-09-04 2012-09-04 Single-chain antibody KGH-R1-ScFv for resisting p21Ras protein and application thereof Pending CN102786596A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012103218945A CN102786596A (en) 2012-09-04 2012-09-04 Single-chain antibody KGH-R1-ScFv for resisting p21Ras protein and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012103218945A CN102786596A (en) 2012-09-04 2012-09-04 Single-chain antibody KGH-R1-ScFv for resisting p21Ras protein and application thereof

Publications (1)

Publication Number Publication Date
CN102786596A true CN102786596A (en) 2012-11-21

Family

ID=47152200

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012103218945A Pending CN102786596A (en) 2012-09-04 2012-09-04 Single-chain antibody KGH-R1-ScFv for resisting p21Ras protein and application thereof

Country Status (1)

Country Link
CN (1) CN102786596A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103880959A (en) * 2014-02-28 2014-06-25 成都军区昆明总医院 Anti-p21ras protein single chain antibody and application thereof
CN103882057A (en) * 2014-02-28 2014-06-25 成都军区昆明总医院 Construction method and application of tumor specific adenovirus vector carrying p21ras single-chain antibody gene
CN103880953A (en) * 2014-03-03 2014-06-25 华南农业大学 Porcine P21 protein antibody as well as preparation method and application thereof
CN113667018A (en) * 2021-08-14 2021-11-19 中国人民解放军联勤保障部队第九二〇医院 BR 2-anti p21Ras single-chain antibody fusion protein capable of entering tumor cells and preparation method thereof
CN113667019A (en) * 2021-08-14 2021-11-19 中国人民解放军联勤保障部队第九二〇医院 ACPP-anti-p 21Ras single-chain antibody fusion protein capable of entering tumor cells and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101057144A (en) * 2004-09-22 2007-10-17 三路影像公司 Methods and compositions for evaluating breast cancer prognosis
CN101724073A (en) * 2010-01-19 2010-06-09 成都军区昆明总医院 Monoclonal antibody of broad spectrum anti-ras gene expressed protein and preparation method thereof
CN101891819A (en) * 2010-06-21 2010-11-24 成都军区昆明总医院 Single-chain antibody of broad-spectrum anti-p21ras protein and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101057144A (en) * 2004-09-22 2007-10-17 三路影像公司 Methods and compositions for evaluating breast cancer prognosis
CN101724073A (en) * 2010-01-19 2010-06-09 成都军区昆明总医院 Monoclonal antibody of broad spectrum anti-ras gene expressed protein and preparation method thereof
CN101891819A (en) * 2010-06-21 2010-11-24 成都军区昆明总医院 Single-chain antibody of broad-spectrum anti-p21ras protein and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
周云刚: "重组p21ras蛋白的表达、鉴定与纯化及其多克隆抗体的制备", 《中国优秀硕士学位论文全文数据库》, 31 December 2009 (2009-12-31) *
陈昊宾: "大肠良恶性病变中p21ras表达研究及其临床病理意义", 《中国优秀硕士学位论文全文数据库》, 31 December 2010 (2010-12-31) *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103880959A (en) * 2014-02-28 2014-06-25 成都军区昆明总医院 Anti-p21ras protein single chain antibody and application thereof
CN103882057A (en) * 2014-02-28 2014-06-25 成都军区昆明总医院 Construction method and application of tumor specific adenovirus vector carrying p21ras single-chain antibody gene
CN103882057B (en) * 2014-02-28 2016-06-22 成都军区昆明总医院 Carry structure and the application thereof of p21ras single-chain antibody gene tomour specific adenoviral vectors
CN103880959B (en) * 2014-02-28 2017-06-09 成都军区昆明总医院 A kind of single-chain antibody of anti-p 21 ras protein and its application
CN103880953A (en) * 2014-03-03 2014-06-25 华南农业大学 Porcine P21 protein antibody as well as preparation method and application thereof
CN103880953B (en) * 2014-03-03 2016-04-20 华南农业大学 One boar P21 protein antibodies and preparation method thereof and application
CN113667018A (en) * 2021-08-14 2021-11-19 中国人民解放军联勤保障部队第九二〇医院 BR 2-anti p21Ras single-chain antibody fusion protein capable of entering tumor cells and preparation method thereof
CN113667019A (en) * 2021-08-14 2021-11-19 中国人民解放军联勤保障部队第九二〇医院 ACPP-anti-p 21Ras single-chain antibody fusion protein capable of entering tumor cells and preparation method thereof
CN113667019B (en) * 2021-08-14 2023-02-03 中国人民解放军联勤保障部队第九二〇医院 ACPP-anti-p 21Ras single-chain antibody fusion protein capable of entering tumor cells and preparation method thereof
CN113667018B (en) * 2021-08-14 2023-02-24 中国人民解放军联勤保障部队第九二〇医院 BR 2-anti-p 21Ras single-chain antibody fusion protein capable of entering tumor cells and preparation method thereof

Similar Documents

Publication Publication Date Title
Baker et al. Designer oncolytic adenovirus: coming of age
Heidbuechel et al. Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies
WO2020125277A1 (en) Genetic engineering modified dual-target chimeric antigen receptor and use thereof
SA516371011B1 (en) Oncolytic adenoviruses armed with heterologous genes
CN109862912A (en) Carry the adenovirus of bispecific T cell adapter (BiTE)
CN102786596A (en) Single-chain antibody KGH-R1-ScFv for resisting p21Ras protein and application thereof
WO2016197592A1 (en) Application of long noncoding rna, hnf1a-as1, in preparing drug for treating human malignant solid tumor
CN109837306A (en) Contain the excretion body and its preparation method and application of miRNA-204-5p
EP3845244A1 (en) Anti-bcma single domain antibodies and application thereof
CN110981972B (en) Chimeric antigen receptor secreting double-specificity antibody and expression vector and application thereof
CN105802909A (en) T cell prepared product having HER2 specific TCR (human epidermal growth factor receptor-2 specific TCR T cell receptor) and application of T cell prepared product
Yousaf et al. Attenuation of the hypoxia inducible factor pathway after oncolytic adenovirus infection coincides with decreased vessel perfusion
CN101891819A (en) Single-chain antibody of broad-spectrum anti-p21ras protein and preparation method thereof
CN102174106B (en) Anti-Met humanized Fab, anti-Met humanized Fab and doxorubicin conjugate and preparation method and application of anti-Met humanized Fab and doxorubicin conjugate
CN101591658B (en) ING4 and IL-24 dual gene co-expression vector and application thereof
CN101768210B (en) Tumor targeting polypeptide and preparation method thereof
CN111956795A (en) Application of chimeric antigen receptor combined anti-tumor drug taking CD99 as target
CN103882057B (en) Carry structure and the application thereof of p21ras single-chain antibody gene tomour specific adenoviral vectors
CN1952160B (en) Recombinant of intelligent adenovirus vector and khp53 gene and application thereof
CN103880959B (en) A kind of single-chain antibody of anti-p 21 ras protein and its application
CN115947865A (en) Chimeric antigen receptor, expression construct, CAR-T cell and application thereof
CN104630146A (en) Preparation method and application of tumour cell specific polyclonal T cells
CN115029320A (en) Engineered exosome for tumor radiotherapy sensitization, preparation method and application
Li et al. Development of Glypican-2 Targeting Single-Domain Antibody CAR T Cells for Neuroblastoma
CN112996909B (en) Oncolytic viruses expressing PD-1 binding proteins and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20121121